扎考必利
化合物
扎考必利（英语：Zacopride），或译为查可必利，是5-HT3受体的有效拮抗剂[1]和5-HT4受体的激动剂。[2]它在动物模型中具有抗焦虑[3]和促智作用，[4]其中(R)-(+)-对映体是更活跃的形式。[5]它还具有止吐[6]和促呼吸作用，在动物研究中既能减少睡眠呼吸暂停，[7]又能逆转阿片类药物引起的呼吸抑制。[8]早期的动物试验还表明，给予扎考必利可以减少对乙醇的偏好和消耗。[9]
 | |
| 臨床資料 | |
|---|---|
| ATC碼 |
|
| 识别信息 | |
| |
| CAS号 | 90182-92-6  |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| 化学信息 | |
| 化学式 | C15H20ClN3O2 |
| 摩尔质量 | 309.79 g·mol−1 |
| 3D模型（JSmol） | |
| |
| |
发现扎考必利在400微克的剂量下显着增加人类受试者的醛固酮水平达180分钟。人们认为这是通过刺激肾上腺上的5-HT4受体来实现的。扎考必利在体外应用于人肾上腺时也能刺激醛固酮分泌。肾素、促肾上腺皮质激素或皮质醇水平未观察到显着变化。[2]
参考资料
- ^ Smith WW, Sancilio LF, Owera-Atepo JB, Naylor RJ, Lambert L. Zacopride, a potent 5-HT3 antagonist. The Journal of Pharmacy and Pharmacology. April 1988, 40 (4): 301–2. PMID 2900319. S2CID 32862252. doi:10.1111/j.2042-7158.1988.tb05253.x.
- ^ 2.0 2.1 Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn JM, et al. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism. December 1993, 77 (6): 1662–6. PMID 8263156. doi:10.1210/jcem.77.6.8263156.
- ^ Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ. Zacopride: anxiolytic profile in rodent and primate models of anxiety. The Journal of Pharmacy and Pharmacology. April 1988, 40 (4): 302–5. PMID 2900320. S2CID 1083706. doi:10.1111/j.2042-7158.1988.tb05254.x.
- ^ Fontana DJ, Daniels SE, Eglen RM, Wong EH. Stereoselective effects of (R)- and (S)-zacopride on cognitive performance in a spatial navigation task in rats. Neuropharmacology. March 1996, 35 (3): 321–7. PMID 8783207. S2CID 12818436. doi:10.1016/0028-3908(96)00191-8.
- ^ Young R, Johnson DN. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice. European Journal of Pharmacology. August 1991, 201 (2–3): 151–5. PMID 1686755. doi:10.1016/0014-2999(91)90338-Q.
- ^ Yamakuni H, Nakayama H, Matsui S, Imazumi K, Matsuo M, Mutoh S. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets. Journal of Pharmacological Sciences. May 2006, 101 (1): 99–102. PMID 16651699. doi:10.1254/jphs.SCJ05007X
.
- ^ Carley DW, Depoortere H, Radulovacki M. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats. Pharmacology, Biochemistry, and Behavior. 2001, 69 (1–2): 283–9. PMID 11420096. S2CID 11848748. doi:10.1016/S0091-3057(01)00535-4.
- ^ Meyer LC, Fuller A, Mitchell D. Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. February 2006, 290 (2): R405–13. PMID 16166206. S2CID 224414. doi:10.1152/ajpregu.00440.2005.
- ^ Knapp DJ, Pohorecky LA. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats. Pharmacology, Biochemistry, and Behavior. April 1992, 41 (4): 847–50. PMID 1594653. S2CID 45436887. doi:10.1016/0091-3057(92)90237-A.
- ^ Newcomer JW, Faustman WO, Zipursky RB, Csernansky JG. Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial. Archives of General Psychiatry. September 1992, 49 (9): 751–2. PMID 1514881. doi:10.1001/archpsyc.1992.01820090079013.
 | 这是一篇作用於神经系统的藥品小作品。您可以通过编辑或修订扩充其内容。 |
 | 这是一篇關於呼吸系統的藥理學小作品。您可以通过编辑或修订扩充其内容。 |